BLOG
Patent analysis and insight
Analysis and insight to bring more predictability, transparency, and equity to your patent prosecution.
(gradient)+(2).png?width=2188&height=463&name=Juristat_Primary+(white+text)(gradient)+(2).png "Juristat | Patent analytics & workflow automation")
(gradient).png?width=2188&height=463&name=Juristat_Primary+(grey+text)(gradient).png "Juristat | Patent analytics & workflow automation")
5 Things In-House Teams Can Do Right Now to Prepare for the Future
Now is not the time to be idle. There are plenty of steps in-house IP departments can take now to ensure team productivity, strategic budgeting, and a strong patent portfolio.
USPTO Extends Deadlines Under CARES Act to June 1, 2020
The USPTO has announced that, in accordance with the CARES Act, it is further extending the deadlines to file certain patent-related documents or fees to June 1, 2020.
How to Evaluate Outside Counsel with Patent Analytics
With budgets tightening and department priorities shifting, now is the time for companies to evaluate outside legal counsel.
The Sky Is Not Falling: COVID-19’s Impact on Patent Filing and Prosecution
Following industry news these days, it’s hard to avoid theories that the economic instability created by COVID-19 will be the death of patent prosecution.
The CARES Act and the USPTO: Are Your Applications Eligible?
Prompted by the CARES Act, the USPTO announced extensions to the time allowed to file certain patent-related documents and to pay certain required fees. Legal teams can use patent analytics tools like Juristat to quickly identify which applications qualify.
How to Use Prosecution Data to Quantify ROI to Clients
As businesses feel the lingering stress from the COVID-19 pandemic, some are considering bringing patent prosecution in-house in order to cut costs. With clients continuing to mind their budgets, how can firms demonstrate the cost savings and ROI they bring to the table?
How to Handle Office Actions More Efficiently
Even during these uncertain times, the USPTO maintains that operations will continue without interruption. That means while you are busy adopting new remote work processes and ensuring your team is healthy, office actions are still being issued.
The Future of Pharma: The AbbVie / Allergan Merger
Biopharmaceutical companies AbbVie Inc. and Allergan recently announced that they signed a consent decree with the U.S. Federal Trade Commission that will commit the companies to sell some properties if they commence a planned merger.
Examiners Who Love (and Hate) to Interview
Contemplating an interview at the USPTO? Our analysis found that nearly 95% of examiners are more likely to allow an application when an interview is part of the prosecution.
7 Tips for Implementing New Legal Tech
Driven by market demand for efficiencies and cost savings, law firms and IP departments are looking to implement more legal technology into their workflow. But after all the work you put into choosing the right tool, how do you get attorneys and staff members to adopt?
Are you ready to transform your patent practice?
Patent prosecution is complex – we know. If you’re ready for simpler workflows and more predictable outcomes, give us a call.